Detail akcie Hologic Inc online

Business Summary: Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
Financial Summary: BRIEF: For the fiscal year ended 28 September 2024, Hologic Inc revenues remained flat at $4.03B. Net income increased 73% to $789.5M. Revenues reflect Breast Health segment increase of 6% to $1.52B, GYN Surgical segment increase of 6% to $641.3M, All Others. segment increase of 9% to $213.9M, Europe segment increase of 2% to $532.7M, Asia segment increase of 2% to $259.6M, also reflect Diagnostics segment decrease of 5% to $1.78B.